CINECA IRIS Institutional Research Information System

MEDICO, Enzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.107
EU - Europa 6.975
AS - Asia 5.064
SA - Sud America 133
OC - Oceania 93
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 20
Totale 25.448
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.909
CN - Cina 2.765
IT - Italia 2.287
SG - Singapore 848
DE - Germania 845
IE - Irlanda 578
SE - Svezia 484
GB - Regno Unito 454
FI - Finlandia 395
FR - Francia 392
AT - Austria 350
JP - Giappone 320
UA - Ucraina 259
KR - Corea 245
IN - India 185
PL - Polonia 180
CA - Canada 158
VN - Vietnam 157
HK - Hong Kong 137
NL - Olanda 134
BE - Belgio 120
BR - Brasile 111
ES - Italia 102
ID - Indonesia 97
TW - Taiwan 92
DK - Danimarca 86
AU - Australia 82
CH - Svizzera 58
RU - Federazione Russa 46
TH - Thailandia 37
TR - Turchia 36
MX - Messico 35
RO - Romania 34
IR - Iran 33
NO - Norvegia 26
SN - Senegal 26
CZ - Repubblica Ceca 24
GR - Grecia 24
PT - Portogallo 23
IL - Israele 20
MY - Malesia 19
EU - Europa 17
PK - Pakistan 12
NZ - Nuova Zelanda 11
UZ - Uzbekistan 11
HU - Ungheria 10
CL - Cile 9
PH - Filippine 9
RS - Serbia 9
ZA - Sudafrica 9
AR - Argentina 7
SK - Slovacchia (Repubblica Slovacca) 7
BA - Bosnia-Erzegovina 6
EG - Egitto 6
LT - Lituania 6
AL - Albania 5
LU - Lussemburgo 5
SA - Arabia Saudita 5
SI - Slovenia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
BN - Brunei Darussalam 4
BY - Bielorussia 4
CO - Colombia 4
HR - Croazia 4
JO - Giordania 4
LK - Sri Lanka 4
MO - Macao, regione amministrativa speciale della Cina 4
NG - Nigeria 4
A1 - Anonimo 3
BD - Bangladesh 3
EE - Estonia 3
KZ - Kazakistan 3
TN - Tunisia 3
AM - Armenia 2
DM - Dominica 2
GE - Georgia 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MK - Macedonia 2
BW - Botswana 1
CU - Cuba 1
CY - Cipro 1
GH - Ghana 1
GL - Groenlandia 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NA - Namibia 1
PS - Palestinian Territory 1
PY - Paraguay 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 25.448
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.514
Chandler 1.106
Fairfield 907
Beijing 817
Houston 727
Singapore 593
Ashburn 586
Dublin 559
Santa Clara 522
Torino 475
Woodbridge 423
Seattle 381
Cambridge 341
Wilmington 338
Shanghai 298
Vienna 294
Dearborn 253
Turin 220
Redwood City 217
Nyköping 204
Pisa 204
Villeurbanne 180
Guangzhou 179
Jacksonville 170
Medford 167
Princeton 153
Warsaw 143
Columbus 141
Milan 134
New York 119
Hangzhou 111
Tokyo 110
Nanjing 104
Lappeenranta 103
Jakarta 90
Dong Ket 89
Helsinki 82
Wuhan 80
Fremont 79
Boardman 71
Brussels 70
Boston 68
San Diego 66
Rome 60
Hong Kong 56
Taipei 55
Genoa 54
Changsha 53
Nuremberg 53
Los Angeles 52
Shenyang 48
Toronto 48
Munich 44
Chengdu 43
London 43
Amsterdam 42
Eitensheim 40
Naples 40
Ottawa 38
Phoenix 38
Zhengzhou 37
Norwalk 35
Silver Spring 35
Paris 34
Nanchang 32
Jinan 29
Verona 29
Washington 29
Xian 29
Falls Church 28
Kunming 28
Bangkok 26
Buffalo 26
Chongqing 26
Fuzhou 26
Seoul 24
Barcelona 23
Belfast 23
Berlin 23
Chicago 23
The Dalles 23
Melbourne 22
Southend 22
Frankfurt am Main 21
Mountain View 21
Bologna 20
Florence 20
Hefei 20
Düsseldorf 18
Moscow 18
Shenzhen 18
Central District 17
Heidelberg 17
Tianjin 17
Bengaluru 16
Hyderabad 16
Oslo 16
São Paulo 16
Upper Marlboro 16
Madrid 15
Totale 16.229
Salva come PNG Salva come JPEG
Nome #
Stromal contribution to the colorectal cancer transcriptome. 1.929
Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer 786
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 750
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 716
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 695
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 594
Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer 590
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. 535
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets 505
MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. 395
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 389
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 347
Patient-derived xenografts and matched cell lines identify pharmacogenomic vulnerabilities in colorectal cancer 344
MicroRNA–mRNA interactions underlying colorectal cancer molecular subtypes 312
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 301
BRAF V600E is a determinant of sensitivity to proteasome inhibitors. 299
Only a subset of Met-activated pathways are required to sustain oncogene addiction 259
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 258
The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer. 255
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 253
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions 250
Transgenic models of cardiac cachexia and cardiac effects of muscular atrophy 250
Truncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cells. 249
Met-driven invasive growth involves transcriptional regulation of Arhgap12 237
Analisi del profilo di trascrizione genetica nella sindrome di Noonan. 234
Transcriptional hallmarks of noonan syndrome and noonan-like syndrome with loose anagen hair 234
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis 231
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 230
The MET oncogene is a functional marker of a glioblastoma stem cell subtype. 229
Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18 F-FDG PET and MRI radiomics features 225
Inhibition of Src impairs the growth of met-addicted gastric tumors. 224
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 219
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 218
Evolving neoantigen profiles in colorectal cancers with DNA repair defects 218
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells 215
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin 207
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 204
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. 203
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 198
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells 197
A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy 195
Exploiting orthologue diversity for systematic detection of gain-of-functionphenotypes 194
Sustained Met signalling in the heart leads to cardiac compensated hypertrophy and remodelling, which evolves into congestive heart failure 187
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK positive anaplastic large cell lymphoma. 186
Detection of gene communities in multi-networks reveals cancer drivers 185
Electrical conditioning of adipose-derived stem cells in a multi-chamber culture platform 180
Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature 178
Mulcom: a multiple comparison statistical test for microarray data in Bioconductor 178
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma 176
A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells 174
IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas 171
A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart 169
Patient-derived xenografts (PDXs) as model systems for human cancer 169
Isolation and Characterization of a Spontaneously Immortalized Multipotent Mesenchymal Cell Line Derived from Mouse Subcutaneous Adipose Tissue 167
Generation of Functional Hepatocytes from Mouse Germline Cell-derived Pluripotent Stem Cells in vitro 164
Semalytics: a semantic analytics platform for the exploration of distributed and heterogeneous cancer data in translational research 160
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study 157
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 155
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. 153
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers 151
PDX-MI: Minimal information for patient-derived tumor xenograft models 149
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles 149
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies 143
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. 141
Knock-in of oncogenic mutations in human somatic cells as a tool to identify genoselective compounds 134
Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. 134
Transcriptional signature of Pseudomyxoma Peritonei: An enhancement of treatment strategy and outcome prediction 133
Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes 132
A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis. 130
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 130
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 128
Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling 127
Formalin fixation at low temperature better preserves nucleic acid integrity. 124
Amplification of repeat-containing transcribed sequences (ARTS): a transcriptome fingerprinting strategy to detect functionally relevant microsatellite mutations in cancer. 123
Anaplastic large-cell lymphoma 123
The miR-126 regulates Angiopoietin-1 signaling and vessel maturation by targeting p85β 120
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES 117
Gene expression profiling of HGF/Met activation in neonatal mouse heart 117
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 112
Reverse signaling by semaphorin 4C elicits SMAD1/5- And ID1/3-dependent invasive reprogramming in cancer cells 111
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer 111
A gene trap vector system for identifying transcriptionally responsive genes 109
Biochemical and immunological properties of the human carcinoma-associated CAR-3 epitope defined by the monoclonal antibody AR-3. 108
Genome-wide analysis of unliganded estrogen receptor binding sites in breast cancer cells 108
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib 107
Biochemical and immunological properties of the human carcinoma antigen CAR-5 defined by the monoclonal antibody BD-5. 106
Cancer and blood coagulation 105
Modeling tumor progression and identifying genotype-drug interactions by the sequential introduction of cancer mutations into the genome of human normal cells 102
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 101
The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma. 98
Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor. 98
Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power 97
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 97
Mek inhibition in a newborn with raf1-associated noonan syndrome ameliorates hypertrophic cardiomyopathy but is insufficient to revert pulmonary vascular disease 97
The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. 93
Ionizing radiation fosters cancer invasion through transcriptional up-regulation of the MET oncogene 92
Molecular anatomy of peripheral T cell lymphomas 90
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 90
A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine 90
The MET oncogene drives a genetic programme linking cancer to haemostasis 89
Totale 22.998
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.084
article - articoli 0
book - libri 0
conference - conferenze 7.593
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.677
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020986 0 0 0 0 0 0 0 0 340 295 200 151
2020/20213.030 173 191 261 188 223 249 301 170 265 292 196 521
2021/20224.747 480 426 408 493 359 332 418 343 220 218 615 435
2022/20233.553 365 295 102 329 324 735 222 259 451 96 217 158
2023/20242.404 247 278 142 162 163 303 157 226 56 213 239 218
2024/20252.901 135 217 278 387 928 375 207 290 84 0 0 0
Totale 26.012